152 related articles for article (PubMed ID: 36863080)
21. Micellar-enhanced and green-assessed first-derivative synchronous spectrofluorimetric approach for concurrent determination of alfuzosin hydrochloride and solifenacin succinate in different matrices: Docking simulation.
Sayed RA; Mohamed AR; Shalaby A; Ibrahim H
Spectrochim Acta A Mol Biomol Spectrosc; 2023 May; 293():122442. PubMed ID: 36758367
[TBL] [Abstract][Full Text] [Related]
22. Solubility determination and solution thermodynamics of olmesartan medoxomil in (PEG-400 + water) cosolvent mixtures.
Al-Shdefat R
Drug Dev Ind Pharm; 2020 Dec; 46(12):2098-2104. PubMed ID: 33151111
[TBL] [Abstract][Full Text] [Related]
23. Second-derivative synchronous spectrofluorimetric determination of nebivolol hydrochloride and amlodipine besylate in their combined dosage form.
Ibrahim F; El-Enany N; Shalan SH; Abo Shabana RA
Luminescence; 2015 Nov; 30(7):1011-9. PubMed ID: 25727077
[TBL] [Abstract][Full Text] [Related]
24. Synchronous fluorescence spectrofluorimetric method for the simultaneous determination of metoprolol and felodipine in combined pharmaceutical preparation.
Walash MI; Belal FF; El-Enany NM; El-Maghrabey MH
Chem Cent J; 2011 Nov; 5(1):70. PubMed ID: 22059735
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of atorvastatin calcium and olmesartan medoxomil in a pharmaceutical formulation by reversed phase high-performance liquid chromatography, high-performance thin-layer chromatography, and UV spectrophotometric methods.
Soni H; Kothari C; Khatri D; Mehta P
J AOAC Int; 2014; 97(3):791-7. PubMed ID: 25051627
[TBL] [Abstract][Full Text] [Related]
26. Spectrofluorimetric investigation for determination of sumatriptan succinate: application to tablets and spiked human plasma.
Abo Zaid MH; Abo El Abass S; El-Enany N; Aly F
Luminescence; 2021 May; 36(3):755-760. PubMed ID: 33368986
[TBL] [Abstract][Full Text] [Related]
27. Green Constant-wavelength Concurrent Selective Fluorescence Method for Assay of Ibuprofen and Chlorzoxazone in Presence of Chlorzoxazone Degradation Product.
Abdallah NA; Fathy ME; Tolba MM; El-Brashy AM; Ibrahim FA
J Fluoresc; 2023 Jul; 33(4):1661-1671. PubMed ID: 36809413
[TBL] [Abstract][Full Text] [Related]
28. Validated spectrofluorimetric assay of two co-administered drug mixtures containing hydroxychloroquine with either moxifloxacin or ofloxacin as a drug regimen for hospital-acquired pneumonia in patients with COVID-19.
El-Sayed A; Elmansi HM; Shalan S; Eid M
Luminescence; 2023 Sep; 38(9):1572-1582. PubMed ID: 37336514
[TBL] [Abstract][Full Text] [Related]
29. Fast concurrent determination of guaifenesin and pholcodine in formulations and spiked plasma using first derivative synchronous spectrofluorimetric approach.
Roshdy A; Salam RA; Hadad G; Belal F; Elmansi H
Luminescence; 2024 Jan; 39(1):e4660. PubMed ID: 38286595
[TBL] [Abstract][Full Text] [Related]
30. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
31. An immunochromatographic strip sensor for rapid and sensitive detection of candesartan, olmesartan medoxomil, and irbesartan in herbal beverages.
Li D; Wu A; Liu L; Kuang H; Xu C; Wu X
Anal Methods; 2024 Apr; 16(15):2359-2367. PubMed ID: 38567492
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous estimation of amlodipine besilate and olmesartan medoxomil in pharmaceutical dosage form.
Wankhede SB; Wadkar SB; Raka KC; Chitlange SS
Indian J Pharm Sci; 2009 Sep; 71(5):563-7. PubMed ID: 20502580
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability Enhancement of Olmesartan Medoxomil Using Hot-Melt Extrusion: In-Silico, In-Vitro, and In-Vivo Evaluation.
Jadhav P; Gokarna V; Deshpande V; Vavia P
AAPS PharmSciTech; 2020 Sep; 21(7):254. PubMed ID: 32888102
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of favipiravir and hydroxychloroquine as FDA-approved drugs for treatment of COVID-19 using synchronous spectrofluorimetry: application to pharmaceutical formulations and biological fluids.
El Sharkasy ME; Tolba MM; Belal F; Walash M; Aboshabana R
Luminescence; 2022 Jun; 37(6):953-964. PubMed ID: 35343627
[TBL] [Abstract][Full Text] [Related]
35. Conventional and first derivative synchronous fluorometric determination of ethamsylate in pharmaceutical preparations and biological fluids. Application to stability studies.
Belal F; El-Brashy A; El-Enany N; Tolba M
J Fluoresc; 2011 Jul; 21(4):1371-84. PubMed ID: 21347837
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of SI/RS-UHPLC-PDA Method for Olmesartan Medoxomil and Metoprolol Succinate-Related Substance.
Thakker N; Shinde G; Dharamsi A; Choudhari V
Turk J Pharm Sci; 2023 Mar; 20(1):39-47. PubMed ID: 36864594
[TBL] [Abstract][Full Text] [Related]
37. Multivariate versus classical univariate calibration methods for spectrofluorimetric data: application to simultaneous determination of olmesartan medoxamil and amlodipine besylate in their combined dosage form.
Darwish HW; Backeit AH
J Fluoresc; 2013 Jan; 23(1):79-91. PubMed ID: 22895851
[TBL] [Abstract][Full Text] [Related]
38. D-optimal design as a useful tool response surface methodology for the optimization of signals from synchronous fluorescence prior to simultaneous determination of avanafil and tadalafil.
Abdel-Raoof AM; Said RAM; Emara MS; El-Desouky EA; Abdelzaher AM; Hasan MA; Osman AE
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jul; 235():118313. PubMed ID: 32251891
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments.
Marisetti VM; Katakam P; Siddhani VK; Katari NK
Biomed Chromatogr; 2021 Nov; 35(11):e5194. PubMed ID: 34110035
[TBL] [Abstract][Full Text] [Related]
40. Micellar-emphasized simultaneous determination of ivabradine hydrochloride and felodipine using synchronous spectrofluorimetry.
Yosrey E; Elmansi H; Sheribah ZA; Metwally ME
Luminescence; 2022 Apr; 37(4):569-576. PubMed ID: 34995408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
